{"id":"https://openalex.org/W2002446900","doi":"https://doi.org/10.1002/j.1552-4604.1998.tb04804.x","title":"The Relevance of T\u2010Type Calcium Antagonists: A Profile of Mibefradil","display_name":"The Relevance of T\u2010Type Calcium Antagonists: A Profile of Mibefradil","publication_year":1998,"publication_date":"1998-08-01","ids":{"openalex":"https://openalex.org/W2002446900","doi":"https://doi.org/10.1002/j.1552-4604.1998.tb04804.x","mag":"2002446900","pmid":"https://pubmed.ncbi.nlm.nih.gov/9725540"},"language":"en","primary_location":{"id":"doi:10.1002/j.1552-4604.1998.tb04804.x","doi":"https://doi.org/10.1002/j.1552-4604.1998.tb04804.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1552-4604.1998.tb04804.x","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012896101","display_name":"Stephen P. Glasser","orcid":"https://orcid.org/0000-0001-9620-6406","observed_orcids":["https://orcid.org/0000-0001-9620-6406"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen P. Glasser","raw_affiliation_strings":["Division of Clinical Pharmacology, University of South Florida, Tampa 33613, USA","Division of Clinical Pharmacology, University of South Florida, Tampa, Florida, and the School of Public Health, Division of Epidemiology, University of Minnesota, Minneapolis, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, University of South Florida, Tampa 33613, USA","institution_ids":["https://openalex.org/I2613432"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, University of South Florida, Tampa, Florida, and the School of Public Health, Division of Epidemiology, University of Minnesota, Minneapolis, Minnesota","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I2613432"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5012896101"],"corresponding_institution_ids":["https://openalex.org/I130238516","https://openalex.org/I2613432"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.1004,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.12017167,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"38","issue":"8","first_page":"659","last_page":"669"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.4634000062942505,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.0348999984562397,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mibefradil","display_name":"mibefradil","score":0.9660000205039978},{"id":"https://openalex.org/keywords/t-type-calcium-channels","display_name":"T-type calcium channels","score":0.9810000061988831},{"id":"https://openalex.org/keywords/l-type-calcium-channels","display_name":"L-type calcium channels","score":0.9940000176429749},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.6159999966621399},{"id":"https://openalex.org/keywords/essential-hypertension","display_name":"essential hypertension","score":0.7889999747276306},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.6690000295639038},{"id":"https://openalex.org/keywords/antianginal-drugs","display_name":"antianginal drugs","score":0.7480000257492065},{"id":"https://openalex.org/keywords/ischemic-heart-disease","display_name":"ischemic heart disease","score":0.6209999918937683},{"id":"https://openalex.org/keywords/supraventricular-arrhythmias","display_name":"supraventricular arrhythmias","score":0.9330000281333923},{"id":"https://openalex.org/keywords/cardiomyopathy","display_name":"cardiomyopathy","score":0.8539999723434448},{"id":"https://openalex.org/keywords/cardiac-hypertrophy","display_name":"cardiac hypertrophy","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cytochrome-p450-metabolism","display_name":"cytochrome P450 metabolism","score":0.8410000205039978},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C2778673320","wikidata":"https://www.wikidata.org/wiki/Q6827783","display_name":"Mibefradil","level":4,"score":0.9959558248519897},{"id":"https://openalex.org/C30979828","wikidata":"https://www.wikidata.org/wiki/Q2487620","display_name":"T-type calcium channel","level":4,"score":0.6780005693435669},{"id":"https://openalex.org/C85520022","wikidata":"https://www.wikidata.org/wiki/Q15322916","display_name":"Calcium channel","level":3,"score":0.5523741841316223},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.5468806624412537},{"id":"https://openalex.org/C18699975","wikidata":"https://www.wikidata.org/wiki/Q14905735","display_name":"Voltage-dependent calcium channel","level":3,"score":0.537613034248352},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5248144865036011},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48728930950164795},{"id":"https://openalex.org/C117499352","wikidata":"https://www.wikidata.org/wiki/Q2600696","display_name":"L-type calcium channel","level":4,"score":0.4686027765274048},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46092578768730164},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3542816638946533},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3260909914970398}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D013764","descriptor_name":"Tetrahydronaphthalenes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013764","descriptor_name":"Tetrahydronaphthalenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020748","descriptor_name":"Mibefradil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/j.1552-4604.1998.tb04804.x","doi":"https://doi.org/10.1002/j.1552-4604.1998.tb04804.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1552-4604.1998.tb04804.x","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:9725540","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9725540","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W28980388","https://openalex.org/W1968598458","https://openalex.org/W1977420468","https://openalex.org/W1980794949","https://openalex.org/W1980970497","https://openalex.org/W1982690791","https://openalex.org/W1982871296","https://openalex.org/W1987416588","https://openalex.org/W1992248060","https://openalex.org/W2000202306","https://openalex.org/W2000344463","https://openalex.org/W2009123418","https://openalex.org/W2012940391","https://openalex.org/W2017405322","https://openalex.org/W2018678361","https://openalex.org/W2020537563","https://openalex.org/W2022941827","https://openalex.org/W2027157785","https://openalex.org/W2034877370","https://openalex.org/W2035590645","https://openalex.org/W2037856128","https://openalex.org/W2038460733","https://openalex.org/W2040569221","https://openalex.org/W2042716907","https://openalex.org/W2042964099","https://openalex.org/W2045673068","https://openalex.org/W2046725590","https://openalex.org/W2048830043","https://openalex.org/W2056325194","https://openalex.org/W2067075698","https://openalex.org/W2072023626","https://openalex.org/W2074231791","https://openalex.org/W2076835537","https://openalex.org/W2086604757","https://openalex.org/W2087671622","https://openalex.org/W2107567093","https://openalex.org/W2114669282","https://openalex.org/W2117405745","https://openalex.org/W2118309627","https://openalex.org/W2123663550","https://openalex.org/W2127011663","https://openalex.org/W2131033837","https://openalex.org/W2134064208","https://openalex.org/W2163958661","https://openalex.org/W2165627388","https://openalex.org/W2170364275","https://openalex.org/W2174190166","https://openalex.org/W2263092743","https://openalex.org/W2321521052","https://openalex.org/W2330817322","https://openalex.org/W2411236507","https://openalex.org/W2412427424","https://openalex.org/W2413904383","https://openalex.org/W2501231229","https://openalex.org/W2725806147"],"related_works":["https://openalex.org/W2033601338","https://openalex.org/W2333746325","https://openalex.org/W2056498332","https://openalex.org/W4296762962","https://openalex.org/W1987627760","https://openalex.org/W2886113429","https://openalex.org/W2023213460","https://openalex.org/W2331406633","https://openalex.org/W1560993600","https://openalex.org/W2261733099"],"abstract_inverted_index":{"L-":[0,66,169],"and":[1,22,25,37,57,67,90,130,170,198,202,221],"T-type":[2,16,68,81,97,110,136,150,171],"voltage-dependent":[3],"transmembrane":[4],"calcium":[5,69,82,88,98,111,137,151,157,172],"channels":[6,17,70,83,99,106,112,138],"are":[7,18,71,107],"important":[8],"for":[9,181],"normal":[10],"functioning":[11],"of":[12,31,49,64,76,80,121,126,135,149,156,177,192],"the":[13,35,47,74,119,159,190,232],"cardiovascular":[14],"system.":[15,40],"a":[19,29,211,217,222],"heterogeneous":[20],"group,":[21],"have":[23,188],"physiologic":[24],"pathophysiologic":[26],"relevance":[27],"in":[28,46,52,58,73,118,128,194],"number":[30],"organ":[32],"systems,":[33],"including":[34],"heart":[36,212],"central":[38],"nervous":[39],"They":[41],"appear":[42,100,114],"to":[43,85,101,115,143,146,166],"be":[44,116,238],"involved":[45,72,117],"control":[48],"blood":[50,196],"pressure":[51,197],"patients":[53],"with":[54,241],"essential":[55],"hypertension":[56],"protection":[59],"from":[60],"ischemic":[61,95],"damage.":[62],"Alterations":[63],"both":[65,168],"development":[75,120],"hypertension.":[77,92],"Pharmacologic":[78],"modulation":[79],"appears":[84],"reduce":[86],"membrane":[87],"flux":[89],"ameliorate":[91],"During":[93],"early":[94],"damage,":[96],"remain":[102],"functional":[103],"whereas":[104],"L-type":[105],"already":[108],"inactivated.":[109],"also":[113],"supraventricular":[122],"arrhythmias,":[123],"some":[124],"forms":[125],"arrhythmias":[127],"cardiomyopathy,":[129],"cardiac":[131],"hypertrophy.":[132],"The":[133,174],"heterogeneity":[134],"should":[139,237],"make":[140],"it":[141,228,236],"possible":[142],"target":[144],"drugs":[145],"specific":[147],"subgroups":[148],"channels.":[152,173],"A":[153],"new":[154],"class":[155,179],"antagonist,":[158],"benzimidazolyl-substituted":[160],"tetraline":[161],"derivatives,":[162],"has":[163,210],"been":[164],"shown":[165],"block":[167],"first":[175],"member":[176],"this":[178],"approved":[180],"clinical":[182],"use":[183],"is":[184,229],"mibefradil.":[185],"Clinical":[186],"studies":[187],"demonstrated":[189],"efficacy":[191],"mibefradil":[193,209],"lowering":[195,214],"as":[199],"an":[200],"antianginal":[201],"antiischemic":[203],"agent.":[204],"At":[205],"clinically":[206],"recommended":[207],"doses,":[208],"rate":[213],"effect":[215,225],"without":[216],"negative":[218],"inotropic":[219],"effect,":[220],"favorable":[223],"side":[224],"profile.":[226],"Because":[227],"metabolized":[230],"by":[231],"cytochrome":[233],"P450":[234],"pathway,":[235],"used":[239],"cautiously":[240],"other":[242],"agents":[243],"similarly":[244],"metabolized.":[245]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}